Lin E - Search Results

1

Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma.

Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Kaseb AO, et al. Among authors: lin e. J Clin Oncol. 2011 Oct 10;29(29):3892-9. doi: 10.1200/JCO.2011.36.0636. Epub 2011 Sep 12. J Clin Oncol. 2011. PMID: 21911725 Free PMC article.

2

I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.

Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. Kaseb AO, et al. Among authors: lin e. Oncology. 2011;80(5-6):373-81. doi: 10.1159/000329040. Epub 2011 Aug 3. Oncology. 2011. PMID: 21822028 Free PMC article.

3

Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial.

Kaseb AO, Garrett-Mayer E, Morris JS, Xiao L, Lin E, Onicescu G, Hassan MM, Hassabo HM, Iwasaki M, Deaton FL, Abbruzzese JL, Thomas MB. Kaseb AO, et al. Among authors: lin e. Oncology. 2012;82(2):67-74. doi: 10.1159/000335963. Epub 2012 Feb 7. Oncology. 2012. PMID: 22327795 Clinical Trial.

4

V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.

Kaseb AO, Hassan MM, Lin E, Xiao L, Kumar V, Pathak P, Lozano R, Rashid A, Abbruzzese JL, Morris JS. Kaseb AO, et al. Among authors: lin e. Cancer. 2011 Jun 1;117(11):2478-88. doi: 10.1002/cncr.25791. Epub 2010 Dec 14. Cancer. 2011. PMID: 24048796 Free PMC article.

5

Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases.

Kesmodel SB, Ellis LM, Lin E, Chang GJ, Abdalla EK, Kopetz S, Vauthey JN, Rodriguez-Bigas MA, Curley SA, Feig BW. Kesmodel SB, et al. Among authors: lin e. J Clin Oncol. 2008 Nov 10;26(32):5254-60. doi: 10.1200/JCO.2008.17.7857. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854565

6

Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma.

Thomas MB, Morris JS, Chadha R, Iwasaki M, Kaur H, Lin E, Kaseb A, Glover K, Davila M, Abbruzzese J. Thomas MB, et al. Among authors: lin e. J Clin Oncol. 2009 Feb 20;27(6):843-50. doi: 10.1200/JCO.2008.18.3301. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139433 Clinical Trial.

7

Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.

Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, Eng C, Abbruzzese JL, Wolff RA. Overman MJ, et al. Among authors: lin e. J Clin Oncol. 2009 Jun 1;27(16):2598-603. doi: 10.1200/JCO.2008.19.7145. Epub 2009 Jan 21. J Clin Oncol. 2009. PMID: 19164203 Clinical Trial.

8

Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases.

Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, Das P, Delclos ME, Janjan NA, Crane CH. Krishnan S, et al. Among authors: lin eh. Am J Clin Oncol. 2006 Dec;29(6):562-7. doi: 10.1097/01.coc.0000236210.41199.91. Am J Clin Oncol. 2006. PMID: 17148992

9

Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.

Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB. Fleming JB, et al. Among authors: lin e. Arch Surg. 2009 Mar;144(3):216-21. doi: 10.1001/archsurg.2008.580. Arch Surg. 2009. PMID: 19289659

10

Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial.

Fogelman D, Jafari M, Varadhachary GR, Xiong H, Bullock S, Ozer H, Lin E, Morris J, Cunningham P, Bennett B, Abbruzzese JL, Wolff RA. Fogelman D, et al. Among authors: lin e. Cancer Chemother Pharmacol. 2011 Dec;68(6):1431-8. doi: 10.1007/s00280-011-1601-4. Epub 2011 Apr 9. Cancer Chemother Pharmacol. 2011. PMID: 21479635 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,788 results

Search Page

Filters